Patent ID: 6251898
Filing Date: 2001-06-26
Classification: C07C,C07D

Abstract:
A method of treating a human patient who is suffering or at risk of central nervous system damage, comprising the step of administering to the patient a pharmaceutical composition which contains a neuroprotective amount of a compound of the formula: ##STR6##wherein X is selected from the group consisting of lower alkyl containing 1 to 3 carbon atoms; substituted lower alkyl; and lower cycloalkyl;wherein R is a substituted alkyl group in which the substituents are selected from the group consisting of aryl and substituted aryl; and substituted or unsubstituted heterocyclic rings having 0 or 1 nitrogen atom and at least one double bond wherein the alkyl group is attached to a carbon atom of the heterocyclic ring; andwherein Y.sup.1 and Y.sup.2 are each selected from the group consisting of halogen, hydrogen, and methyl.